The global pulse oximeters market size was accounted for USD 2.49 billion in 2024, grew to USD 2.72 billion in 2025 and is predicted to surpass around USD 6.08 billion by 2034, representing a healthy CAGR of 9.33% between 2025 and 2034. The North America pulse oximeters market size was calculated at USD 1.22 billion in 2024 and is expected to grow at a fastest CAGR of 9.45% during the forecast year
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Pulse Oximeters Market, by Product Type, 2025-2034
7.1.1. Handheld Oximeters
7.1.1.1. Market Revenue and Forecast (2022-2034)
7.1.2. Fingertip Oximeters
7.1.2.1. Market Revenue and Forecast (2022-2034)
7.1.3. Tabletop Oximeters
7.1.3.1. Market Revenue and Forecast (2022-2034)
8.1. Pulse Oximeters Market, by End-user, 2025-2034
8.1.1. Ambulatory Surgical Centers
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Home Healthcares
8.1.3.1. Market Revenue and Forecast (2022-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.2. Market Revenue and Forecast, by End-user (2022-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.3.2. Market Revenue and Forecast, by End-user (2022-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.4.2. Market Revenue and Forecast, by End-user (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.2. Market Revenue and Forecast, by End-user (2022-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.3.2. Market Revenue and Forecast, by End-user (2022-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.4.2. Market Revenue and Forecast, by End-user (2022-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.5.2. Market Revenue and Forecast, by End-user (2022-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.6.2. Market Revenue and Forecast, by End-user (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.2. Market Revenue and Forecast, by End-user (2022-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.3.2. Market Revenue and Forecast, by End-user (2022-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.4.2. Market Revenue and Forecast, by End-user (2022-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.5.2. Market Revenue and Forecast, by End-user (2022-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.6.2. Market Revenue and Forecast, by End-user (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.2. Market Revenue and Forecast, by End-user (2022-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.3.2. Market Revenue and Forecast, by End-user (2022-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.4.2. Market Revenue and Forecast, by End-user (2022-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.5.2. Market Revenue and Forecast, by End-user (2022-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.6.2. Market Revenue and Forecast, by End-user (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.2. Market Revenue and Forecast, by End-user (2022-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.3.2. Market Revenue and Forecast, by End-user (2022-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.4.2. Market Revenue and Forecast, by End-user (2022-2034)
10.1. Smiths Group plc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Halmaplc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Koninklijke Philips N.V.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Medtronic plc
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Nihon Kohden Corporation
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Masimo Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Contec Medical Systems Co., Ltd.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Omron healthcare, Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. General Electric Company
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Nonin Medical, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client